How to Diagnose and Risk Stratify Brugada Syndrome. Comment on Matusik et al. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. J. Clin. Med. 2023, 12, 6581
Conflicts of Interest
References
- Matusik, P.T.; Bijak, P.; Kaznica-Wiatr, M.; Karpinski, M.; Matusik, P.S.; Maziarz, A.; Podolec, P.; Lelakowski, J. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. J. Clin. Med. 2023, 12, 6581. [Google Scholar] [CrossRef] [PubMed]
- Shinohara, T.; Takagi, M.; Kamakura, T.; Sekiguchi, Y.; Yokoyama, Y.; Aihara, N.; Hiraoka, M.; Aonuma, K.; Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Risk stratification in asymptomatic patients with Brugada syndrome: Utility of multiple risk factor combination rather than programmed electrical stimulation. J. Cardiovasc. Electrophysiol. 2021, 32, 507–514. [Google Scholar] [CrossRef] [PubMed]
- Kataoka, N.; Imamura, T. Brugada Syndrome: A Comprehensive Review of Fundamental and Electrophysiological New Findings. J. Clin. Med. 2023, 12, 6590. [Google Scholar] [CrossRef] [PubMed]
- Miles, C.; Boukens, B.J.; Scrocco, C.; Wilde, A.A.M.; Nademanee, K.; Haissaguerre, M.; Coronel, R.; Behr, E.R. Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation. Circulation 2023, 147, 1622–1633. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kataoka, N.; Imamura, T. How to Diagnose and Risk Stratify Brugada Syndrome. Comment on Matusik et al. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. J. Clin. Med. 2023, 12, 6581. J. Clin. Med. 2023, 12, 7548. https://doi.org/10.3390/jcm12247548
Kataoka N, Imamura T. How to Diagnose and Risk Stratify Brugada Syndrome. Comment on Matusik et al. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. J. Clin. Med. 2023, 12, 6581. Journal of Clinical Medicine. 2023; 12(24):7548. https://doi.org/10.3390/jcm12247548
Chicago/Turabian StyleKataoka, Naoya, and Teruhiko Imamura. 2023. "How to Diagnose and Risk Stratify Brugada Syndrome. Comment on Matusik et al. Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. J. Clin. Med. 2023, 12, 6581" Journal of Clinical Medicine 12, no. 24: 7548. https://doi.org/10.3390/jcm12247548